Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Centrica North Sea losses seen higher, reiterates FY guidance

(Sharecast News) - British energy and services firm Centrica reiterated its FY guidance on Thursday despite warning that losses were expected to increase at its Centrica Energy Storage+ subsidiary, which operates the UK's largest gas storage site in the North Sea. Centrica cautioned that "challenging market conditions" in gas and power meant that profits at Centrica Energy, its energy and logistics division, would now sit at the lower end of guidance, while Centrica Energy Storage+, which runs the North Sea's Rough gas field, was expected to see losses come in at the higher end of its £50.0m to £100.0m guidance.

However, the FTSE 100-listed group still reiterated FY profit guidance and revealed its annual dividend payout would be hiked to 5.5p per share, up from 3.0p per share a year earlier.

Centrica also noted that "constructive discussions" with Westminster were ongoing as it looks to secure a regulatory support mechanism that would unlock £2.0bn of investment to increase the Rough gas field's capacity and ultimately convert it into a hydrogen-ready storage facility.

"The usual uncertainties remain for the balance of the year, including weather, commodity prices, regulation and government policy. As is normal, Ggroup profitability is expected to be weighted to the first half of the year," said Centrica.

"We are closely monitoring the impact of potential global trade restrictions and will continue to do so. Given our diversified supply chains across key projects and operations, we do not currently anticipate any material impact on our business or financial results."

As of 0840 BST, Centrica shares were down 7.07% at 147.80p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.